BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 6203206)

  • 41. Biological markers in prostate cancer.
    Pontes JE
    J Urol; 1983 Dec; 130(6):1037-47. PubMed ID: 6196490
    [No Abstract]   [Full Text] [Related]  

  • 42. [An immunohistochemical study of prostate antigen using an enzyme-labeled antibody technique].
    Okano M; Deguchi T; Takeuchi T; Kuriyama M; Nishiura T
    Hinyokika Kiyo; 1983 Oct; 29(10):1369-71. PubMed ID: 6085712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunohistochemical study of prostatic acid phosphatase and prostatic specific antigen in prostatic carcinoma--a comparison of monoclonal antibody to polyclonal antibody].
    Moriyama N; Taniguchi J; Hara M; Fukutani K; Matsushima H; Murakami T; Isurugi K; Kawabe K; Niijima T
    Nihon Hinyokika Gakkai Zasshi; 1987 Nov; 78(11):1992-7. PubMed ID: 2453695
    [No Abstract]   [Full Text] [Related]  

  • 44. Naturally occurring prostate cancer antigen-specific T cell responses of a Th1 phenotype can be detected in patients with prostate cancer.
    McNeel DG; Nguyen LD; Ellis WJ; Higano CS; Lange PH; Disis ML
    Prostate; 2001 May; 47(3):222-9. PubMed ID: 11351352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum prostate-specific antigen: its use in diagnosis and management of prostate cancer.
    Lange PH; Brawer MK
    Urology; 1989 Jun; 33(6 Suppl):13-7. PubMed ID: 2471346
    [No Abstract]   [Full Text] [Related]  

  • 46. [Purification and determination of human prostate specific antigen in the serum].
    Ogawa Y; Morikawa J; Ohsawa R; Machida T; Miki M; Yanagisawa M
    Radioisotopes; 1984 May; 33(5):273-8. PubMed ID: 6206524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Purification and enzyme immunoassay of tumor markers for prostate cancer: prostatic acid phosphatase, prostate-specific antigen and creatine kinase BB].
    Morishita N; Minami Y; Ogawa S; Saito Y
    Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):404-13. PubMed ID: 6206268
    [No Abstract]   [Full Text] [Related]  

  • 48. Uses and limitations of prostate-specific antigen in the laboratory diagnosis of prostate cancer.
    Wells DJ; Bennett BD; Gardner WA
    South Med J; 1988 Feb; 81(2):218-20. PubMed ID: 2448884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical demonstration of prostate-specific antigen in metastases with the use of monoclonal antibody F5.
    Papsidero LD; Croghan GA; Asirwatham J; Gaeta J; Abenoza P; Englander L; Valenzuela L
    Am J Pathol; 1985 Dec; 121(3):451-4. PubMed ID: 2416221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of gonadotropin-releasing hormone analogue in advanced prostatic cancer: 3 years clinical experience.
    Matzkin H; Greenstein A; Kaver I; Braf Z
    Isr J Med Sci; 1989 Jul; 25(7):388-92. PubMed ID: 2474522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Schistosomiasis, metaplasia and squamous cell carcinoma of the prostate: histogenesis of the squamous cancer cells determined by localization of specific markers.
    Al Adnani MS
    Neoplasma; 1985; 32(5):613-22. PubMed ID: 2415839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Is the prostate-specific antigen useful in the detection of prostatic cancer?].
    Morote Robles J; Ruibal Morell A
    Med Clin (Barc); 1987 Nov; 89(15):663. PubMed ID: 2448558
    [No Abstract]   [Full Text] [Related]  

  • 53. Anti-human prostatic acid phosphatase (P.A.P.) monoclonal antibodies: characterisation and practical application.
    Teillac P; Leroy M; Rabaud B; Le Duc A; Najean Y
    Prog Clin Biol Res; 1987; 243A():485-7. PubMed ID: 3659007
    [No Abstract]   [Full Text] [Related]  

  • 54. [Prostate-specific antigen in the diagnosis of prostatic carcinoma].
    Virseda JA; Morente M; Piris MA; Melchor AM; Gil Pascual B; Gómez A
    Actas Urol Esp; 1985; 9(1):89-94. PubMed ID: 2409752
    [No Abstract]   [Full Text] [Related]  

  • 55. Acid phosphatase.
    Henneberry MO; Engel G; Grayhack JT
    Urol Clin North Am; 1979 Oct; 6(3):629-41. PubMed ID: 388794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cancer of the prostate: prostatic acid phosphatases. Biochemical properties and assay].
    Jardillier JC; Desoize B; Delvincourt C
    Bull Cancer; 1985; 72(6):519-26. PubMed ID: 3912016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The detection of cancer of the prostate. Challenge for the 1990s?].
    Boccon-Gibod L
    Ann Urol (Paris); 1988; 22(6):385-7. PubMed ID: 2464966
    [No Abstract]   [Full Text] [Related]  

  • 58. A prostate antigen in sera of prostatic cancer patients.
    Papsidero LD; Wang MC; Valenzuela LA; Murphy GP; Chu TM
    Cancer Res; 1980 Jul; 40(7):2428-32. PubMed ID: 7388802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
    Koh E; Sekii K; Namiki M; Fujioka H; Onoue K; Sakurai M; Sonoda T
    Eur Urol; 1987; 13(1-2):142-4. PubMed ID: 2438138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Enzyme-linked immunosorbent assay for serum prostate specific antigen (PSA) using monoclonal antibodies].
    Setoguchi C; Matsumoto K; Samori T; Kimura E; Harukaze S
    Rinsho Byori; 1998 Jan; 46(1):79-82. PubMed ID: 9492543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.